Forschung in Hamburg - ©
Fraunhofer © Fraunhofer IME

European Screening Port integrated into Fraunhofer IME

Hamburg strenghtens and expands its drug research and expertise. Integration will bring along new co-operations.

The Free and Hanseatic City of Hamburg will fund the integration and future growth of the new IME ScreeningPort with three million euro. Dr. Dorothee Stapelfeld, Hamburg Minister of Science, emphasises: “It has been an important target in the Senate’s strategy to integrate the European Screening Port in the Fraunhofer Gesellschaft to develop specific pre-clinical drug development in Hamburg. By networking with scientists at the DESY and the University Medical Centre, and Evotec as industrial partner, a first-class R & D location has thus been created.”

International research

At the new site in Hamburg, 30 employees will add their scientific skills and expertise to the 600 personnel currently working on IME research activities, creating a new organisation called the IME-ScreeningPort (IME-SP). The new organization will act as a platform between basic research and industrial development and exploit synergies with other IME technology platforms along the drug discovery and development value chain. The Fraunhofer Institute for Molecular Biology and Applied Ecology IME is located in Aachen and operates branches in Gießen, Frankfurt, Münster, Schmallenberg and international centres in the USA and Chile.


Further details:

On European ScreeningPort GmbH (ESP)

The European Screening Port GmbH in Hamburg’s Park Labs was founded in Hamburg in 2007 as a public-private partnership of the Free and Hanseatic City of Hamburg and Evotec AG. The company is active in the field of pharmaceutical drug discovery. It aims to bridge the gap between basic research on the causes of disease and the development of drugs from pharmaceutical companies. ESP is one of the global leaders in field of screening of small molecules positioned for academic goals.

More articles

  • There are no older articles in this category.
  • There are no newer articles in this category.